Overview

Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Single centre, open-label, randomised study in four parallel groups of healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Eslicarbazepine acetate